Participant flow and baseline characteristics
stroke, hypoplasia of the GSV
STROKE
Between April 2015 and July 2019, some 480 patients met the criteria for eligibility and were randomized to either SAP or TAP. Of these, 464 patients received the allocated treatment. Sixteen patients were excluded because they no longer met the inclusion criteria (1 patient had a tributary unsuitable for phlebectomy, 1 patient appeared to have hypoplasia of the GSV in the thigh unsuitable for EVLA, 11 patients no longer wanted to participate, 1 patient could not be instructed sufficiently owing to a recent stroke, and in 2 patients there was no longer a clear indication for treatment) (CONSORT diagram for trialSAP, isolated ambulatory phlebectomy with or without delayed endovenous truncal ablation; TAP, thermal ablation with concomitant phlebectomy; EVLA, endovenous laser ablation; ITT, intention to treat.Patient and treatment characteristics at baseline according to treatment receivedValues are 